Krishna Institute of Medical Sciences Ltd Stock Price Today (NSE: KIMS)

Krishna Institute of Medical Sciences Ltd

746.407.50 (0.99%)
Market Closed

Fundamental Score

...

Krishna Institute of Medical Sciences Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Krishna Institute of Medical Sciences Ltd share price today is 746.40, down 0.99% on NSE/BSE as of 2 June 2026. Krishna Institute of Medical Sciences Ltd (KIMS) is a Large-cap company in the Hospital sector with a market capitalisation of 27.61K (Cr). The 52-week high for KIMS share price is 798.40 and the 52-week low is 575.80. At a P/E ratio of 83.99x, KIMS is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 18.48% and a debt-to-equity ratio of 1.40.

Krishna Institute of Medical Sciences Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
791.15
Low
650.05
Volume
6.0L
Change
+16.31%

Krishna Institute of Medical Sciences Ltd share price chart: 16.31% return over the past month. 52-week high ₹798.40, 52-week low ₹575.80.

Krishna Institute of Medical Sciences Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
765.05789.90753.65784.453.40L (Cr)
758.60774.50749.95767.752.90L (Cr)
769.95769.95744.05756.802.33L (Cr)
773.00775.00757.15764.101.70L (Cr)
756.00771.00747.50769.152.30L (Cr)
739.60761.90725.15755.805.42L (Cr)
722.50745.00716.00741.055.96L (Cr)
748.00755.00714.00716.855.42L (Cr)
771.50782.00748.05761.655.92L (Cr)
779.85790.60767.10773.307.09L (Cr)

Krishna Institute of Medical Sciences Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
672.00791.15663.00784.45+16.73%
630.10691.90613.00666.70+5.81%
712.35735.00610.80621.50-12.75%
593.00757.50578.60745.05+25.64%
610.50667.15575.80603.75-1.11%
690.25712.00599.85608.60-11.83%
724.50733.45653.65685.10-5.44%
700.15742.80676.80721.05+2.99%
721.50772.00697.30700.15-2.96%
755.20773.00692.65723.90-4.14%
673.00798.40660.90751.20+11.62%
686.00690.95616.35673.60-1.81%

Returns & Performance

Good

Return on Equity (ROE)

18.48%

Profit generated per ₹1 of shareholder equity

Average

Return on Capital (ROCE)

15.00%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

27.57%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Krishna Institute of Medical Sciences Ltd Valuation Check

Poor

Price to Earnings (P/E)

83.99x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

52.84x

Average P/E of all peers in this sector

Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.

Shareholding Pattern

Excellent

Promoter Holding

34.11%

% shares held by company founders/management

Good

FII Holding

15.03%

% shares held by foreign institutional investors

Excellent

DII Holding

32.12%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-37.45%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

23.59%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

22.01%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

23.23%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

25.01%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.40x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.60x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-228.14 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Krishna Institute of Medical Sciences Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of KIMS across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Strong Return on Equity (18.48%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (15.00%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (27.57%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (23.59%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (22.01% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (23.23% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (25.01% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Institutional Confidence (FII+DII: 47.15%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Premium Valuation Risk (P/E: 83.99x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-37.45%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Elevated Debt Levels (D/E: 1.40)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Negative Free Cash Flow (₹-228.14 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Krishna Institute of Medical Sciences Ltd vs Hospital Peers

Peer Comparison - Hospital

Compare Krishna Institute of Medical Sciences Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
45.1/100
746
₹27605.54
84.0
Average
18.48%
Good
15.00%
Good
1.4
Average
25.01%
Excellent
22.01%
Excellent
0.00%
69.1/100
1069
₹109416.28
77.7
Average
12.72%
Average
14.88%
Average
0.3
Excellent
80.50%
Excellent
46.01%
Excellent
0.13%
50.2/100
8273
₹104825.94
62.7
Average
18.42%
Good
16.64%
Good
0.9
Good
33.72%
Excellent
14.15%
Good
0.26%
55.6/100
961
₹68301.24
67.8
Average
10.13%
Average
11.96%
Average
0.3
Excellent
70.31%
Excellent
10.93%
Good
0.11%
62.2/100
1884
₹39051.19
45.9
Average
24.22%
Excellent
20.75%
Excellent
0.6
Good
43.49%
Excellent
11.88%
Good
0.24%
15.4/100
741
₹34688.15
94.5
Average
8.26%
Poor
10.68%
Average
0.5
Excellent
-7.24%
Poor
-13.71%
Poor
0.75%
61/100
1240
₹33498.00
56.0
Average
16.48%
Good
19.74%
Good
0.3
Excellent
70.15%
Excellent
19.73%
Excellent
0.04%
51.2/100
480
₹16844.04
145.2
Average
4.76%
Poor
9.99%
Poor
0.5
Good
41.72%
Excellent
26.38%
Excellent
0.00%
54.6/100
1351
₹13410.38
52.8
Average
17.43%
Good
18.69%
Good
0.5
Good
33.66%
Excellent
16.08%
Excellent
0.23%
36.4/100
647
₹10474.40
296.2
Average
5.14%
Poor
8.56%
Poor
1.9
Average
19.34%
Excellent
15.22%
Excellent
0.00%
62.9/100
1329
₹9678.17
48.8
Average
14.95%
Average
17.95%
Good
0.3
Excellent
43.62%
Excellent
22.20%
Excellent
0.07%

Krishna Institute of Medical Sciences Ltd PE Ratio History

Historical price-to-earnings ratio for KIMS — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20259.61₹608.6063.3x
FY 20247.75₹598.0077.2x
FY 20238.41₹1979.20235.5x
FY 20228.38₹1547.30184.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Krishna Institute of Medical Sciences Ltd Quarterly Performance

Latest quarterly metrics for KIMS — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

23.59%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-37.45%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

22.01%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

25.01%

Compounded annual net profit growth over 5 years

Krishna Institute of Medical Sciences Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for KIMS — calculated from daily price history

64RSI 14
Neutral — RSI 64

Momentum is balanced — neither overbought nor oversold.

SMA 50
686
▲ Price above SMA 50 — Short-term bullish
SMA 200
690
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
596K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Krishna Institute of Medical Sciences Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Krishna Institute of Medical Sciences Ltd (KIMS) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Krishna Institute of Medical Sciences Ltd

About KIMS (Krishna Institute of Medical Sciences Ltd)

Krishna Institute of Medical Sciences Ltd is a beacon of hope and healing, a multi-specialty hospital group renowned for its advanced medical infrastructure and compassionate patie...nt care. Towering structures house state-of-the-art operating theaters equipped with robotic surgical systems, cutting-edge diagnostic imaging centers, and specialized intensive care units designed to meet the diverse needs of critically ill patients. Stepping inside, one is immediately enveloped in an atmosphere of clinical precision blended with human empathy, as highly trained medical professionals collaborate seamlessly to deliver personalized treatment plans. The hospital's corridors resonate with the quiet hum of sophisticated medical equipment, a testament to its commitment to embracing technological advancements for improved patient outcomes. Each ward is meticulously maintained, offering a sanctuary of comfort and tranquility for those on their journey to recovery. Within KIMS, a constellation of medical specialties thrives, each department a center of excellence dedicated to pushing the boundaries of medical knowledge. Neurological disorders find sophisticated diagnosis and treatment within specialized units, supported by advanced neuro-imaging and rehabilitation programs. The heart center pulsates with innovation, offering a comprehensive range of cardiac services from minimally invasive procedures to complex heart transplants. Respiratory ailments are addressed with cutting-edge interventions, including advanced diagnostics, interventional pulmonology, and lung transplantation. The digestive health institute stands as a leader in gastrointestinal care, performing intricate surgeries and offering advanced treatments for liver and pancreatic diseases. KIMS embraces holistic healthcare, incorporating preventative medicine, wellness programs, and patient education to empower individuals to take control of their health. At the heart of KIMS lies a dedicated team of physicians, surgeons, nurses, and support staff united by a common mission: to provide exceptional healthcare with unwavering compassion. These highly skilled professionals are not only experts in their respective fields but also empathetic caregivers who understand the importance of human connection in the healing process. Every patient is treated with dignity and respect, their individual needs carefully considered in the development of a tailored treatment plan. KIMS fosters a culture of continuous learning and improvement, encouraging its staff to participate in ongoing research and training programs to stay at the forefront of medical innovation. This commitment to excellence ensures that patients receive the highest quality care, delivered with empathy and precision.

Company Details

Symbol:KIMS
Industry:Hospital
Sector:Hospital

Key Leadership

Dr. Bhaskara Rao Bollineni
Founder, MD & Executive Chairman
Dr. Abhinay Bollineni
CEO & Executive Director
Mr. Sachin Ashok Salvi
Chief Financial Officer

KIMS Share Price: Frequently Asked Questions

What is the current share price of Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd (KIMS) trades at ₹746.40 on NSE and BSE. Market cap ₹27.61K (Cr). Educational data only.

What is the P/E ratio of Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd has a P/E of 83.99x vs industry average 52.84x.

What is the Bull Run score for Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd has a Bull Run score of 45.1/100 based on 25+ financial parameters.

Does Krishna Institute of Medical Sciences Ltd pay dividends?

Krishna Institute of Medical Sciences Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd has ROE of 18.48%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Krishna Institute of Medical Sciences Ltd?

Krishna Institute of Medical Sciences Ltd has debt-to-equity of 1.40.

Is Krishna Institute of Medical Sciences Ltd a good investment?

Bull Run gives Krishna Institute of Medical Sciences Ltd a score of 45.1/100. This is not investment advice — consult a SEBI-registered advisor.